Mengru Gao, Jisong Liu, Miaomiao Yang, Xiangzhou Zhang, Yulian Zhang, Zhuliang Zhou, Jiabin Deng: Integrative analysis of autophagy-related genes reveals that CAPNS1 is a novel prognostic biomarker and promotes the malignancy of melanoma via Notch signaling pathway. Am J Cancer Res 2024;14(8):3665-3693. (Full text, PDF)
Yung-Chia Kuo, Chen-Yang Huang, Cedric Chuan Young Ng, Chiao-Yun Lin, Wen-Kuan Huang, Li-Yu Lee, Hsien-Chi Fan, An-Chi Lin, Kai-Jie Yu, See-Tong Pang, Bin Tean Teh, Cheng-Lung Hsu: Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model. Am J Cancer Res 2024;14(8):3694-3710. (Full text, PDF)
Yiqi Liu, Haobing Li, Xiangyu Shen, Ying Liu, Xiaoxiao Zhong, Jing Zhong, Renxian Cao: PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis. Am J Cancer Res 2024;14(8):3711-3732. (Full text, PDF)
Xiao-Xia Chi, Peng Ye, Neng-Qi Cao, Wei-Lun Hwang, Jong-Ho Cha, Mien-Chie Hung, Kai-Wen Hsu, Xiu-Wen Yan, Wen-Hao Yang: PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma. Am J Cancer Res 2024;14(8):3733-3756. (Full text, PDF)
Shuqiao Xing, Zhenrong Xiong, Mengmeng Wang, Yifan Li, Jiali Shi, Yiming Qian, Jia Lei, Jiamei Jia, Weiquan Zeng, Zhihui Huang, Yuanyuan Jiang: Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway. Am J Cancer Res 2024;14(8):3757-3772. (Full text, PDF)
Wei-Bo Tang, Wen-Hang Wang, Hyoung Jae Lee, Jie Zhou, Xu-Ben Yu, Quan Zhou, Sayeon Cho, Kwonseop Kim: δ-catenin promotes Twist1 stabilization in prostate cancer through ubiquitination modification. Am J Cancer Res 2024;14(8):3773-3788. (Full text, PDF)
Mee Young Kim, Hyong Woo Moon, Min Soo Jo, Ji Youl Lee: Exosomal miR-664a-5p as a therapeutic target biomarker for PARP inhibitor response in prostate cancer. Am J Cancer Res 2024;14(8):3789-3799. (Full text, PDF)
Xinqi Lou, Yuanyuan Wang, Yanjun Deng, Jiao Yang, Duo Xu, Mingdeng Wang, Yuansheng Lin: Prognostic and immunological roles of RSPO1 in pan-cancer and its correlation with LUAD proliferation and metastasis. Am J Cancer Res 2024;14(8):3800-3815. (Full text, PDF)
Chie Kudo-Saito, Satoko Matsumura, Taisuke Mori, Yoshitaka Honma, Seiichi Yoshimoto: Prognostic significance of the FSTL1-DIP2A axis in early-stage tongue cancer. Am J Cancer Res 2024;14(8):3816-3825. (Full text, PDF)
Wei Zhao, Chao Xie, Kukun Hanjiaerbieke, Rui Xu, Tuxunjiang Pahati, Shaoyu Wang, Junjie Li, Yunling Wang: Predictive machine learning models based on VASARI features for WHO grading, isocitrate dehydrogenase mutation, and 1p19q co-deletion status: a multicenter study. Am J Cancer Res 2024;14(8):3826-3841. (Full text, PDF)
Ji Won Seo, Ki Bum Park, Seung Taek Lim, Kyong Hwa Jun, Hyung Min Chin: Machine learning models for prediction of lymph node metastasis in patients with T1b gastric cancer. Am J Cancer Res 2024;14(8):3842-3851. (Full text, PDF)
Shoma Mori, Takayoshi Maiguma, Keisuke Yoshii, Yasushi Moriya, Ryo Takada, Fumitaka Shinkai, Yuto Haruki, Hikari Hashimoto, Atsushi Komoto, Kazunobu Takayanagi, Koji Tamura, Yusuke Okura, Tetsuhiro Sugiyama, Kenichi Shimada: Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective study. Am J Cancer Res 2024;14(8):3852-3858. (Full text, PDF)
Xi Chen, Lei Ji, Xiaoyan Qian, Min Xiao, Qing Li, Qiao Li, Jiayu Wang, Ying Fan, Yang Luo, Bo Lan, Shanshan Chen, Fei Ma, Binghe Xu, Pin Zhang: Evolution and prognostic significance of HER-2 conversion from primary to residual disease in HER-2 negative patients with breast cancer after neoadjuvant chemotherapy. Am J Cancer Res 2024;14(8):3859-3872. (Full text, PDF)
Ami E Sedani, Ogechi Jessica Obidike, Aldenise P Ewing, Kelly K Rifelj, Joenn Kim, Shelly Wright, Sharon Carothers, Rebekah R Mullins, Curt Pesmen, Phuong Ly-Gallagher, Charles R Rogers: #CRCandMe: results of a pre-post quasi-experimental study of a mass media campaign to increase early-onset colorectal cancer awareness in Utah and Wisconsin. Am J Cancer Res 2024;14(8):3873-3884. (Full text, PDF)
Xian Ge, Meiling Hua, Yuan Zhan: Gastric adenocarcinoma with intestinal progenitor cell differentiation: a morphologically underdiagnosed and more invasive distinctive type of gastric adenocarcinoma. Am J Cancer Res 2024;14(8):3885-3895. (Full text, PDF)
Bin Wang, Xiaobo Peng, Jie Li, Yiran Wang, Longpei Chen, Meihong Wu, Yingyi Zhang, Wei Wang, Dan Feng, Shuhui Tang, Linli Zhang, Xianbao Zhan: Personalized mRNA vaccine combined with PD-1 inhibitor therapy in a patient with advanced esophageal squamous cell carcinoma. Am J Cancer Res 2024;14(8):3896-3904. (Full text, PDF)
Xucai Zheng, Puze Tang, Hui Li, Tingbo Ye, Xu Zhu, Wei He, Ling Cheng, Huaidong Cheng: Cucurbitacin E elicits apoptosis in laryngeal squamous cell carcinoma by enhancing reactive oxygen species-regulated mitochondrial dysfunction and endoplasmic reticulum stress. Am J Cancer Res 2024;14(8):3905-3921. (Full text, PDF)
Meng Fan, Jin Tang, Wei Du, Yang-Feng Du, Hai-Jun Liu: Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer. Am J Cancer Res 2024;14(8):3922-3934. (Full text, PDF)
Yu Tian, Lixin Tang, Xin Wang, Yanqin Ji, Yanyang Tu: Nrf2 in human cancers: biological significance and therapeutic potential. Am J Cancer Res 2024;14(8):3935-3961. (Full text, PDF)
Mengjie Luo, Qi Li, Qingdan Gu, Chunlei Zhang: Fusobacterium nucleatum: a novel regulator of antitumor immune checkpoint blockade therapy in colorectal cancer. Am J Cancer Res 2024;14(8):3962-3975. (Full text, PDF)
Juncheng Xuhong, Nisha Wu, Qiyun Shi, Hao Tian, Zaihui Peng, Jun Jiang, Jing Zhang, Xiaowei Qi: Targeted multimodal synergistic therapy of drug-resistant HER2-positive breast cancer by pyrotinib-ICG self-assembled nanoparticles. Am J Cancer Res 2024;14(8):3976-3993. (Full text, PDF)
Yiting Meng, Jin Feng, Jianghui Yang, Hongfang Yin: Clinicopathological characteristics of endometrial carcinoma with different molecular subtypes and their correlation with lymph node metastasis. Am J Cancer Res 2024;14(8):3994-4003. (Full text, PDF)
Matthew GK Benesch, Rongrong Wu, Colin J Rog, David N Brindley, Takashi Ishikawa, Kazuaki Takabe: Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression. Am J Cancer Res 2024;14(8):4004-4027. (Full text, PDF, Supplementary Table 1)
Ashiq Ali, Saba Manzoor, Tayyab Ali, Muhammad Asim, Ghulam Muhammad, Aftab Ahmad, Mohamad Ikhwan Jamaludin, Sutha Devaraj, Nayla Munawar: Innovative aspects and applications of single cell technology for different diseases. Am J Cancer Res 2024;14(8):4028-4048. (Full text, PDF)
Hongli Wang, Jiandao Hu, Weibang Zhou, Aijuan Qian: Metabolic reprogramming in the pathogenesis and progression of nasopharyngeal carcinoma: molecular mechanisms and therapeutic implications. Am J Cancer Res 2024;14(8):4049-4064. (Full text, PDF)
Min Yi, Kai Zheng, Qian Ning, Yu Nie, Fuguo Huang: Screening for the presence of aberrantly expressed ACTR2 in osteosarcoma and analyzing its mechanism of action through an online database. Am J Cancer Res 2024;14(8):4065-4081. (Full text, PDF, Supplementary Material)
Dongwei Yao, Feng Xin, Xiaozhou He: RNF26-mediated ubiquitination of TRIM21 promotes bladder cancer progression. Am J Cancer Res 2024;14(8):4082-4095. (Full text, PDF)
Retraction: Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK. Am J Cancer Res 2024;14(8):4096. (Full text, PDF)
